rs7920186
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The ENST00000305242.10(ODAD2):c.1238G>A(p.Arg413Gln) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R413G) has been classified as Benign.
Frequency
Consequence
ENST00000305242.10 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ODAD2 | NM_018076.5 | c.1238G>A | p.Arg413Gln | missense_variant, splice_region_variant | 9/20 | ENST00000305242.10 | NP_060546.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ODAD2 | ENST00000305242.10 | c.1238G>A | p.Arg413Gln | missense_variant, splice_region_variant | 9/20 | 1 | NM_018076.5 | ENSP00000306410 | P1 |
Frequencies
GnomAD3 genomes AF: 0.118 AC: 15233AN: 129232Hom.: 734 Cov.: 16
GnomAD3 exomes AF: 0.0983 AC: 7234AN: 73570Hom.: 347 AF XY: 0.0982 AC XY: 3592AN XY: 36582
GnomAD4 exome AF: 0.109 AC: 51564AN: 473844Hom.: 2223 Cov.: 5 AF XY: 0.110 AC XY: 27792AN XY: 251896
GnomAD4 genome AF: 0.118 AC: 15271AN: 129338Hom.: 742 Cov.: 16 AF XY: 0.116 AC XY: 7179AN XY: 62150
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 17, 2018 | - - |
Primary ciliary dyskinesia Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Primary ciliary dyskinesia 23 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at